Tyson Foods leverages a diversified protein portfolio, strong chicken performance and global expansion to deliver resilient growth, rising profits and long-term shareholder value.

Innovative Medicine unit is showing a growth trend, driven by existing products like Darzalex, Tremfya and Erleada and continued uptake of new launches, including Spravato, Carvykti and Tecvayli.

Netflix’s accelerating ad business, AI-driven innovation, content strength, focus on originals across various genres and languages are key positives.

Broadcom is a leading player in the semiconductor market based on its expanding product portfolio, multiple target markets, accretive acquisitions and strong cash flow.

AT&T is witnessing early momentum in its core market areas driven by strength in 5G and fiber, as it aims to better harness edge computing capabilities with core business focus.

Align Technology’s robust product line, balanced growth across all channels and consistent focus on international markets to drive growth bolster our confidence in the stock.

Amgen’s key medicines like Evenity and Repatha as well as newer medicines like Tavneos and Tezspire are driving sales, more than offsetting declining revenues from oncology biosimilars and legacy established products such as Enbrel

Robust vehicle offerings, a growing software and services business, progress in China restructuring, and investor-friendly moves are expected to support General Motors’ growth. 

Microsoft’s cloud dominance with Azure, AI leadership and diversified revenue streams will continue to generate sizeable cash flows.

Target’s accelerating digital ecosystem, marketplace expansion, shrink improvement, and high-margin non-merchandise streams, supported by advanced tech and AI, enhance profitability and omnichannel scale.